Aug. 14 at 3:55 PM
$TENX 2 hedgefund buying in 17% of the outstanding is wild with 118 million in cash
First Quarter 2026 Financial Results
Cash position: Tenax Therapeutics reported cash and cash equivalents of
$118.8 million as of March 31, 2026. The proceeds from exercises of previously issued warrants during the quarter have enabled Tenax to extend its cash runway, and the Company now expects cash and cash equivalents to fund it through at least the first quarter of 2028.
$CAPR $RDDT $KPTI
